Back

Genomic and TCR Repertoire Intratumor Heterogeneity of Small-cell Lung Cancer and its Impact on Survival

Chen, M.; Chen, R.; Jin, Y.; Li, J.; Zhang, J.; Fujimoto, J.; Lee, W.-C.; hu, x.; Hubert, S. M.; George, J.; Hu, X.; Chen, Y.; Behrens, C.; Chow, C.-W.; Pham, H. H. N.; Fukuoka, J.; Parra, E. R.; Gay, C. M.; Little, L. D.; Gumbs, C.; Song, X.; Diao, L.; Wang, Q.; Cardnell, R.; Zhang, J.; Wang, J.; Gibbons, D. L.; Heymach, J.; Lee, J. J.; William, W. N.; Glisson, B.; Wistuba, I.; Futreal, P. A.; Thomas, R. K.; Reuben, A.; Byers, L.; Zhang, J.

2020-07-02 genomics
10.1101/2020.06.30.180844 bioRxiv
Show abstract

Small-cell lung cancer (SCLC) is speculated to harbor complex genomic intratumor heterogeneity (ITH) associated with high recurrence rate and suboptimal response to immunotherapy. Here, we revealed a rather homogeneous mutational landscape but extremely suppressed and heterogeneous T cell receptor (TCR) repertoire in SCLCs. Higher mutational burden, lower chromosomal copy number aberration (CNA) burden, less CNA ITH and less TCR ITH were associated with longer overall survival of SCLC patients. Compared to non-small cell lung cancers (NSCLCs), SCLCs had similar predicted neoantigen burden and mutational ITH, but significantly more suppressed and heterogeneous TCR repertoire that may be associated with higher CNA burden and CNA ITH in SCLC. Novel therapeutic strategies targeting CNA could potentially improve the tumor immune microenvironment and response to immunotherapy in SCLC.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.